.jpg)
Predicting conformational movements in proteins is one of the most complex challenges in computational biology. Unlike static structure prediction, capturing the dynamics of these molecules requires models that understand how they change shape over time, especially the slow, large-scale movements that determine essential biological functions. In this context, the PETIMOT (Protein sEquence and sTructure-based Inference of MOTions) model proposes an innovative approach: using SE(3)-equivariant neural networks together with transfer learning from pre-trained protein language models. The key lies in a loss function that respects natural symmetries such as scaling and permutation, allowing the inference of continuous movements from sparse experimental observations. This advance not only surpasses traditional physics-based methods and modern diffusion or flow approaches in accuracy and speed, but also opens the door to practical applications in drug design and disease understanding.
To develop and implement solutions of this level, organizations need a technology partner that offers high-impact AI for businesses, combining artificial intelligence with robust infrastructure. At Q2BSTUDIO we create custom applications that integrate complex models like PETIMOT into real workflows. Our services range from AWS and Azure cloud services to scale the training of equivariant networks, to AI agents that automate the analysis of protein dynamics. Additionally, we apply cybersecurity to protect sensitive research data and use Power BI to visualize conformational results in interactive dashboards. If your company seeks to implement custom software that turns cutting-edge research into productive solutions, our team is ready to collaborate.
The combination of artificial intelligence and business intelligence services allows extracting actionable knowledge from complex biological models. PETIMOT is an example of how scientific innovation is enhanced by the right technological development; at Q2BSTUDIO we help organizations take that step, creating platforms that bridge computational biology with data-driven decision making.
